Find information on Industry Analysis Report

Posts tagged ‘Drugs’

Report on 2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry was professional and depth research report on China Synthesis Polypeptide Drug industry. The report firstly introduced Synthesis Polypeptide Drug basic information included Synthesis Polypeptide Drug definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Synthesis Polypeptide Drug industry policy and plan, Synthesis Polypeptide Drug product specification, manufacturing process, product cost structure etc. then statistics China key manufacturers Synthesis Polypeptide Drug capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Synthesis Polypeptide Drug products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed China Synthesis Polypeptide Drug capacity production capacity market share production market share supply demand shortage import export consumption etc data statistics, and then introduced China Synthesis Polypeptide Drug 2009-2013 capacity production price cost profit production value gross margin etc information. http://www.bharatbook.com/healthcare-market-research-reports/2012-deep-research-report-on-global-and-china-synthesis-polypeptide-drug-industry.html

And also listed Synthesis Polypeptide Drug upstream raw materials equipments and Sharp Solarnstream clients alternative products survey analysis and Synthesis Polypeptide Drug marketing channels industry development trend and proposals. In the end, this report introduced Synthesis Polypeptide Drug new project SWOT analysis Investment feasibility analysis investment return analysis and also give related research conclusions and development trend analysis of China Synthesis Polypeptide Drug industry. In a word, it was a depth research report on China Synthesis Polypeptide Drug industry. And thanks to the support and assistance from Synthesis Polypeptide Drug industry chain related technical experts and marketing engineers during Research Team survey and interviews.

Table of Contents
Chapter One Synthesis Polypeptide Drug Industry Overview 1
1.1 Synthesis Polypeptide Drug Definition 1
1.2 Synthesis Polypeptide Drug Classification and Application 3
1.3 Professional Terms Interpretation 8
1.4 Synthesis Polypeptide Drug Industry Chain Structure 12
1.5 Synthesis Polypeptide Drug Industry Overview 14

Chapter Two Synthesis Polypeptide Drug International and China Market Analysis 16
2.1 Synthesis Polypeptide Drug Industry International Market Analysis 16
2.1.1 Synthesis Polypeptide Drug International Market Development History 16
2.1.2 Synthesis Polypeptide Drug Product and Technology Developments 18
2.1.3 Synthesis Polypeptide Drug Competitive Landscape Analysis 25
2.1.4 Synthesis Polypeptide Drug International Key Countries Development Status 28
2.1.5 Synthesis Polypeptide Drug International Market Development Trend 30
2.2 Synthesis Polypeptide Drug China Market Analysis 33
2.2.1 Synthesis Polypeptide Drug China Market Development History 33
2.2.2 Synthesis Polypeptide Drug Product and Technology Developments 33
2.2.3 Synthesis Polypeptide Drug Competitive Landscape Analysis 35
2.2.4 Synthesis Polypeptide Drug China Key Regions Development Status 37
2.2.5 Synthesis Polypeptide Drug China Market Development Trend 37
2.3 Synthesis Polypeptide Drug International and China Market Comparison Analysis 42

Chapter Three Major Synthesis Polypeptide Drug Analysis 43
3.1 Immunity Regulating Medicine (Allergy Infection and Immune) 43
3.1.1 Glatiramer Injection (Glatiramer Acetate) 43
3.1.2 Thymalfasin for Injection 46
3.1.3 Thymopentin Injection 49
3.1.4 Thymopetidum Injection 53
3.1.5 Summary 55
3.2 Digestive System Drugs (Gastrointestinal Type) 57
3.2.1 Octreotide Acetate Injection 57
3.2.2 Somatostatin for Injection 61
3.3 Bone and Connective Tissue Types (Thyroid hormones Drug) 66
3.3.1 Salmon Calcitonin Injection 67
3.3.2 Elcatonin Injection 70
3.3.4 TerfparaLide Injectlon 72
3.4 Gynecologic or Obstetric Drug 76
3.4.1 Oxytocin Injection 76
3.4.2 Carbetocin Injection 81
3.4.3 Acetate Atosiban Injection 83
3.5 Tumor Drug (hCG) 86
3.5.1 Leuprorelin Acetate Microspheres for Injection 87
3.5.2 Goserelin Acetate 89
3.5.3 Triptorelin Acetate Injection 92
3.5.4 Chorionic Gonadotrophin for Injection 95
3.6 Urinary System Drug (Diabetes Insipidus) 98
3.6.1 Desmopressin Acetate Injection 98
3.6.2 Terlipressin for Injection 101
3.7 Metabolic Drug (Insulin and Other Hypoglycemic Agents) 105
3.7.1 Biosynthetic Glucagon for Injection 105
3.7.2 Exenatide Injection 106

For more information kindly visit :
Report on 2012 Deep Research Report on Global and China Synthesis Polypeptide Drug Industry

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://3marketresearchreport.blogspot.in/

The World Medical Markets Fact Book 2012

The indispensable source of thousands of facts, figures and statistics for 66 medical markets worldwide!
The World Medical Markets Fact Book 2012 is the ideal companion in today’s challenging medical market environment. The need to understand world medical marketplaces, and be able to answer quickly those questions that arise daily, is essential. That is why this current and comprehensive source of key market statistics is an invaluable aid for every medical device industry executive.

Proven and reliable
Published by Espicom, for over 30 years experts in the healthcare market field, the 400-page Fact Book brings together a range of often difficult to source information in one single, convenient and comprehensive publication. Keep it near to you at all times.

The World Medical Markets Fact Book 2012 quickly answers key market questions
How are the economic downturn and currency fluctuations affecting expenditure in key Asian markets?
Which medical device sectors are growing the fastest and where?
How does the Brazilian medical market compare with China and India in terms of total health expenditure?
What demographic development is affecting the market in Central and Eastern Europe?
What have been the key trends affecting medical technology companies in leading Latin American markets?

66 Key countries covered
Argentina
Australia
Austria
Bangladesh
Belarus
Belgium
Brazil
Bulgaria
Canada
Chile
China
Colombia
Croatia
Cuba
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iran
Ireland
Israel
Italy
Japan
Jordan
Latvia
Lithuania
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Pakistan
Peru
Philippines
Poland
Portugal
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
UAE
United Kingdom
USA
Venezuela
Vietnam

Comprehensive Contents
World Overview Medical equipment market (actual and per capita) Consumables
Diagnostic imaging
Dental products
Orthopaedic & prosthetic devices
Patient aids
Others

Trade in medical equipment
Economic data and health expenditure
Demographics
Healthcare data Hospitals and beds
Admissions and surgical procedures
Physicians, nurses, pharmacists and dentists

Regional Overviews
The report provides 5 regional overviews for: Americas
Asia/Pacific
Central/Eastern Europe
Middle East/Africa
Western Europe

Which provide data on:
Market data by product sector Trade data
Economic data
Demographics
Health expenditure
Healthcare data Hospitals and beds
Admissions and surgical procedures
Physicians, nurses, pharmacists and dentists

Key facts and figures for 66 markets:
Market Data by product sector: 2006-2011 Consumables, Diagnostic imaging, Dental products,
Orthopaedic & prosthetic devices, Patient aids, Others
Trade Data: 2006-2011 Imports/Import growth rate
Exports/Export growth rate

Economic Data: 2006-2011
Health expenditure (US$ billions)
Health expenditure per capita (US$)
Health expenditure as a % of GDP
Public health expenditure as a % of the total

Demographic Data: 2006-2011
Population
Population growth
% population aged 65+
Live births per ’000 population
Deaths per ’000 population
Infant mortality per ‘000 live births
Life expectancy for males/females

Healthcare Data: 2006-2011
Hospitals (public and private)
Hospital beds
Beds per ‘000 population
Inpatient admissions
Inpatient admissions per ‘000 population
Average length of stay (days)
Surgical procedures (‘000’s)
Outpatient visits
Outpatient visits per ‘000 population
Nurses per ‘000 population
Physicians per ‘000 population
Dentists
Dentists per ‘000 population
Pharmacists
Pharmacists per ‘000 population

For more information kindly visit :
The World Medical Markets Fact Book 2012

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://3marketresearchreport.blogspot.in/
http://healthcareraj.blogspot.com/

Printed Electronics for Healthcare and Beauty

Printed electronics for healthcare and beauty encompasses stretchable, flexible, conformal and sometimes biodegradable electronics and electrics. It is very thin and lightweight, even in hybrid constructions that, for now, incorporate conventional integrated circuits (IC), light emitting diodes (LED) and other chips in a partly printed device in order to perform functions not yet possible with entirely printed surfaces. Saving up to 40% of cost, space and weight and making new things possible are typical achievements. This is the only up to date, comprehensive report on this rapidly emerging technology and covers; electronic medical implants, patches, disposables, and drug and cosmetic dispensing: stretchable, flexible, wide area, low cost, disposable electronics.

Printed and potentially printed thin film electronics provides many benefits in healthcare and beauty including low cost in many cases, even to the point of disposability, and greatly enhanced functionality in other cases. Frequently, it makes new things possible. It does this in two ways. It is the basis of totally new components relying on new physical principles, examples including metamaterials and memristors. Secondly it makes possible the creation of new devices such as self-powered implants that never need a battery to be replaced. Battery replacement by surgical procedure causes up to 3% of fatalities.

All this addresses the modern needs of healthcare in the private house and on-the-go and more effective, affordable healthcare and beauty products that are easier to use, unobtrusive, greener, automatic and safer. The greying of the population and lack of staff and facilities for conventional healthcare are addressed.

This new technology takes an increasing variety of forms from implants to smart skin patches, radio frequency identification (RFID) and smart packaging. The human interface is improved with sound, moving images, light emitting graphics and so on. Other functions achieved are as widely different as automatic drug delivery and anticounterfeiting. Multiple benefits are commonplace. In a drug trial, recording which pill was removed, when, and plotting this helps patients to do better – get well sooner – and reduces the amount of corrupt data.

Printed electronics is therefore helping to prevent sickness and reduce errors, drive down costs and crime and improve product performance. For the user, it makes life easier, safer and more enjoyable. To the supplier, it is an opportunity to finally nail supply chain inefficiencies to increase market share and profit. Sometimes, it can justify premium pricing and reinvigorate brands, partly with packaging that becomes part of the product in a more meaningful way and with much more sophisticated, relevant electronic rewards incorporated. On the other hand, a niche product such as a medical instrument can become a volume product usable by almost anyone.

This profusely illustrated report takes a very broad view of the subject so the reader does not miss commercial opportunities because of the relatively narrow focus of the research community. Tables and charts compare the technical, market and other options, navigate the jargon and reveal trends. Leveraging the large IDTechEx database on the subject, its coverage in relevant IDTechEx events and a wide range of personal contacts reinforced by intensive travel, the subject is brought alive without equations or obscure science but with the fruits of research by the highly qualified and experienced IDTechEx team.

For more information kindly visit :
Printed Electronics for Healthcare and Beauty

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://3marketresearchreport.blogspot.in/
http://healthcareraj.blogspot.com/

Dermatological Drugs: World Market Prospects 2012-2022

Where are dermatological treatments heading? Visiongain’s report shows you potential revenues to 2022, with data, forecasts and discussions.
This study assesses drugs to treat human skin disorders. You discover sales predictions at world market, therapeutic submarket, product and national levels to 2022.
How will 24 leading drugs – Valtrex, Zovirax, Protopic, Enbrel and others – perform from 2012? Our report gives you business research and analysis with many sales forecasts.

Also, you see forecasting of five derma submarkets to 2022, finding potential revenues:
Dermatitis
• Psoriasis
• Acne
• Infectious skin diseases
• Miscellaneous dermatologics.

What does the future hold? The pharma industry has potential for improved treatments and increased revenues from dermatological agents. The R&D pipeline is strong.
Our report discusses GSK, Galderma, Amgen, Abbott, J&J and other pharmaceutical companies, assessing prospects of the industry and market.
Many commercial opportunities in treating skin disorders remain, including increased revenues. You can investigate the future of that area now.
Visiongain’s study provides data, analysis and opinion aiming to benefit your research, calculations, meetings and presentations. You find answers in our work.
Revenue forecasts, market shares, developmental trends and discussions

In our report you find revenue forecasting, growth rates and market shares. Also, you have qualitative analyses (including SWOT) and discussion of R&D activities. You receive 121 tables and charts and a research interview.
Advantages of Dermatological Drugs: World Market Prospects 2012-2022 for your work

In particular, this study gives you the following knowledge on the topic:
• Find potential revenues to 2022 for the world market and submarkets
• Discover revenue forecasts to 2022 for 24 leading products
• See market forecasting to 2022 for the US, Japan, the EU5, China and India
• Assess leading companies, discovering activities and outlooks
• Review R&D, seeing pipeline trends
• Investigate competition and opportunities influencing sales
• Find out what will stimulate and restrain the industry and market
• View opinion from the sector, receiving primary research.

There, you find a distinctive mix of quantitative and qualitative analyses with independent predictions. Without our report, you could miss out on information that your competitors are using.
We investigate commercial applications of dermatology, helping you to stay ahead.
Gain business research and analysis for the treatment of skin disorders
Our study is for everybody needing industry and market analyses for dermatological drugs. Find data, trends and answers. Avoid missing out – please order our report now.

Table of Contents
1. Executive Summary
1.1 World Dermatological Drug Market: Overview of Findings
1.2 Aims, Scope and Format of the Report
1.3 Research and Analysis Methods
2. Introduction to Dermatological Disorders and Their Treatments
2.1 An Introduction to Dermatology
2.1.1 The Structure of the Skin
2.1.2 Hair
2.1.3 Nails
2.1.4 Sweat and Sebaceous Glands
2.2 Functions of the Skin
2.2.1 Protection
2.2.2 Sensation
2.2.3 Vitamin D Synthesis
2.2.4 Temperature Regulation and Heat Insulation

For more information kindly visit :
Dermatological Drugs: World Market Prospects 2012-2022

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://healthcareraj.blogspot.com/

Cell-Based Assays: World Market Prospects 2012-2022

What does the future hold for cell-based assays in pharma? Visiongain’s report shows you potential revenues and other trends, with data, forecasts and discussions.
Our study analyses products and services for cell-based testing. It covers activities of product developers and pre-clinical contract research organisations.
You discover sales predictions to 2022 at world market, main submarket and national levels. Find potential revenues for products and services.
Also, you receive discussions of many companies in the cell assay industry, seeing their activities and outlooks.

Companies featured include the following:
• BD Biosciences
Life Technologies
• PerkinElmer
• Beckman Coulter
• Evotec
• GE Healthcare
• Thermo Fisher Scientific
• Covance
• PPD
• Charles River Laboratories
• MD Biosciences.

Looking ahead to 2022, many commercial opportunities exist for cell-based testing. Our report gives you business research and analysis there.
Where are cellular assays heading? Greater need for cellular information earlier in pre-clinical product development stimulates demand for the tests. Our report shows you how their use is increasing in drug discovery and development.
Which developmental processes will benefit most from cell assays? This decade, drug screening and toxicity testing will be important applications for cell-based products and services, our analysis shows.
At present, half of all assays used in pharmaceutical development are cell-based. Miniaturisation and automation are important. We find wide scope for developing the systems and applications from 2012 to 2022, seeing many opportunities.
What are the limitations of cell-based assays? For their potential to be achieved, challenges must be tackled. Systems such as 3D assays will allow for more-accurate simulation of in vivo conditions in cell cultures. Our report explains.
Visiongain’s study provides data, analysis and opinion aiming to benefit your research, calculations and presentations. You find answers now in our work.

Revenue forecasts, market shares, developmental trends and discussions
In our report you find revenue forecasting, growth rates and market shares. Also, you have qualitative analyses (SWOT and STEP) and discussion of technologies, existing and in development. You receive 74 tables and charts and two research interviews.
Advantages of Cell-Based Assays: World Market Prospects 2012-2022 for your work

In particular, this study gives you the following knowledge:
• Find potential revenues to 2022 for the world market and submarkets
• See market forecasting to 2022 for US, Japan, EU5, China and India
• Assess leading companies, discovering activities and outlooks
• Review technological developments, assessing trends and prospects
• Investigate competition and opportunities influencing revenues
• Find out what will stimulate and restrain the industry and market
• Analyse pharma R&D spending by stage and find an overall forecast to 2022
• View opinions from our survey, receiving detailed interviews.

There, you find a distinctive mix of quantitative and qualitative analyses with independent predictions. Without our report, you could miss out on information that your competitors are using.
We analyse developments and prospects in cellular testing, helping you to stay ahead.
Gain business research and analysis for cell-based assays
Our study is for everybody needing industry and market analyses for cell assays. Find data, trends and answers. Avoid missing out – please order our report now.

For more information kindly visit :
Cell-Based Assays: World Market Prospects 2012-2022

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://healthcareraj.blogspot.com/

China Healthcare Market Analysis

Healthcare system in China is witnessing series of transformation driven by government backed reform process and increasing private sector participation. Although China healthcare market is fraction of the developed markets, it is actually witnessing double digit growth in recent years. However, within the Chinese healthcare market landscape,there still exists huge difference between the tier one cities and the rural areas. Within the city, there exist huge difference in the level of healthcare services provided by the hospital and small clinics. Chinese healthcare market is very diverse in nature due to presence of multiple hierarchies of healthcare institutions offering services to largest population base in the world.

With improvement in the healthcare infrastructure, the Chinese Healthcare Industry is entering into a new era of development. Moreover, increased government spending, has accelerated the development of healthcare infrastructure in China. Large population base having large proportion of ageing people and continuously growing prevalence of lifestyle diseases are further supporting the advancement of the industry. With 1.3 Billion people, China has a huge opportunity in terms of potential patients. However, a closer look at the composition of China s populace reveals a much smaller, although still very large, likely patient pool. Approximately 600 Million people are considered urban residents, while over 700 Million are considered rural residents in China. The rural population is disadvantaged in terms of access to and quality of care. Nevertheless, even without significant uptake in rural patients, China health-care market could continue growing at an intense pace.

The total healthcare expenditure accounts for only about 5% of the total GDP in China, this percentage has increased over the past few years. Compared with developed countries, this 5% is relatively low. However, with the development of the economy, there is still a great potential for increasing the healthcare expenditure’s percentage of the GDP.

“China Healthcare Market Analysis” research report gives detailed overview on the multiple aspects related to healthcare system in China. It helps to understand the recent reform process started by the government and its impact on healthcare market in future. This research report also helps to analyze ongoing trends and the healthcare infrastructure and human resources in China.

Table of Contents
1. China Healthcare System Overview
2. Healthcare Regulatory & Policy Framework
2.1 Ministry Of Health
2.2 National Essential Medicine System
2.3 New Social Insurance Law
3. Healthcare Reforms Process
3.1 Healthcare Spending By Government
3.2 Efficient Delivery Of Healthcare Services
3.3 Availability Of Drugs
3.4 Strengthening Public Hospital Infrastructure
4. Healthcare Infrastructure At National & Provincial Level
4.1 Public & Private Hospitals
4.2 Grass-Roots Healthcare Institution
4.3 Specialized Public Health Institution
4.4 Hospitals Beds
5. Healthcare Professionals At National & Provincial Level
5.1 Doctor & Assistant Doctor
5.2 Nurse
5.3 Pharmacist
5.4 Laboratory Technician
5.5 Village Doctors & Assistants
6. Hospitals Visits: Inpatients & Outpatients
7. Infectious Disease Profile
8. Hospital Income & Expenditure
9. Healthcare Sector Trends
9.1 Ageing Population
9.2 Central & Local Government Healthcare Spending
9.3 Emergence Of Private Medical Insurance Sector
9.4 Health Insurance Subsidy By Government
9.5 Rising Venture Capital/Private Equity Investments
9.6 Private Clinics As Specialized Medical Centers
10. Healthcare Cities
10.1 Shanghai International Medical Zone
10.2 China Medical City
11. Competitive Landscape
11.1 Chindex International
11.2 Shanghai International Medical Center
11.3 Beijing Tongren Hospital
11.4 Zhongshan Hospital
11.5 Changzheng Hospital
11.6 Renji Hospital

For more information kindly visit :
China Healthcare Market Analysis

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://twitter.com/#!/bharatbook
http://healthcareraj.blogspot.com/

Understanding South Korean Regional Health Markets

Critical information and statistics on national and regional health infrastructure and provision. An essential source of detailed key business data on this fast growing economy.

South Korea is one of the more dynamic and advanced Asian medical markets with a well established health infrastructure and national health insurance system. Trends in South Korean society, however, present opportunities for medical and pharmaceutical companies. Notably the country’s increasing aged population which stands at 11% of the population is set to reach 20% by 2025. In addition, a push for a slice of the growing global health tourist trade is just one driver in the expansion of advanced facilities.

Identifying opportunities in South Korea’s valuable and rapidly expanding health economy requires detailed knowledge of the economic performance, health infrastructure and health personnel distribution at a state/territory level. Being able to see that in the context of neighbouring provinces and the national picture brings focus to areas of opportunity and need.

Rich in statistics, charts and maps, this new report (June 2012) Understanding Regional South Korean Health Markets takes you further into understanding the dynamic regional health sector. A comprehensive introduction sets the national scene while summary data for each region highlights the key economic characteristics and health infrastructure. Comparative statistics are provided for each region and can be seen in the light of national averages.

How is the population and wealth regionally distributed?
Which provinces produce the highest levels of GDP?
How is the aging population changing the nature of health provision and long-term care?
What is the primary and secondary health infrastructure in each region?
How is healthcare delivered?
What is the changing role played by private/government health provision?Which regions are better provided for and which still need investment?

Access to this report includes the brilliant Espicom Interactive with machine translation into Korean!

Customers can choose print or pdf format but all get access via Espicom Interactive. This report is rich in charts and tables and Espicom Interactive “one click” extraction of data in MS Excel™ and MS PowerPoint™ means you can easily build the data into your own reports and systems and text can be machine translated into 9 different languages – including Korean.

FULL REPORT CONTENTS FOR UNDERSTANDING REGIONAL SOUTH KOREAN HEALTH MARKETS
Geography
Political and Economic Background
Politics
Economy
Demography
Population
Demographic Indicators
Births
Deaths
Infant Mortality
Life Expectancy
Morbidity
Communicable Diseases
HIV/AIDS
Non-communicable Diseases
Cancer
Cardiovascular Disease
Diabetes
Mortality

Healthcare Sector
Organisation
Healthcare Funding
Healthcare Delivery
Private Sector
First Foreign Owned Hospital to Open in 2013
Medical Tourism Marketing Legalised
Jeju Medical Tourism Project
Health Expenditure
Organisation of Expenditure
Public Sector
Private Sector
WHO Estimates of Health Expenditure
Locally-Sourced Expenditure Data
Primary Care
Primary Care Activity
Hospital Facilities
Hospital Activity
Patient Survey
Surgical Procedures
Hospital Outpatient Visits
Medical Personnel
Provincial Data Comparisons Seoul National Capital Area / Sudogwan
Gyeonggi Province
Seoul Metropolitan City
Incheon Metropolitan City
Yeongnam Region
Gyeongsangbuk Province
Gyeongsangnam Province
Busan Metropolitan City
Daegu Metropolitan City
Ulsan Metropolitan City
Hoseo Region
Sejong Special Autonomous City
Chungcheongbuk Province
Chungcheongnam Province
Daejeon Metropolitan City
Honam Region
Jeollabuk Province
Jeollanam Province
Gwangju Metropolitan City
Gangwong Region
Gangwon Province
Jeju Province

For more information kindly visit :
Understanding South Korean Regional Health Markets

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://in.linkedin.com/pub/bharat-book/3a/98/512
http://healthcareraj.blogspot.com/

Tag Cloud